A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
Clinical trial NCT05477849 · RECRUITING
Trial details
- NCT number
- NCT05477849
- Sponsor
- Shanghai Virogin Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2025-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.